ProPhase Labs, Inc.

NasdaqCM:PRPH 株式レポート

時価総額:US$86.8m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

ProPhase Labs 過去の業績

過去 基準チェック /06

主要情報

1.4%

収益成長率

6.8%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率35.3%
株主資本利益率-52.6%
ネット・マージン-82.2%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

Mar 04
Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

Jan 09
ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Sep 21
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

Aug 11
Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

Apr 07
We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

Jan 24
ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential

Oct 13

ProPhase Labs Q2 2022 Earnings Preview

Aug 10

We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

Jul 26
We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

ProPhase Labs to license two investigational cancer compounds from Global BioLife

Jul 21

ProPhase Labs: A Stellar Quarter And Another Special Dividend

May 16

ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 08
ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely

Mar 23
ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely

Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt

Nov 30
Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt

As Employer Vaccine Mandates Fail, Prophase Labs Could Benefit

Oct 20

Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Jul 22
Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants

Jun 28

Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More

May 14
Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More

ProPhase Labs partners with Dutchess County New York to provide COVID-19 testing

May 06

A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Apr 12
A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

ProPhase Labs opens Covid testing facility in New York

Jan 29

収支内訳

ProPhase Labs の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqCM:PRPH 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Mar 2429-24342
31 Dec 2344-17353
30 Sep 2363-10397
30 Jun 2379-4389
31 Mar 23947359
31 Dec 22123183413
30 Sep 22146312912
30 Jun 22131272811
31 Mar 22111182710
31 Dec 217962210
30 Sep 2139-5187
30 Jun 2133-2146
31 Mar 21280105
31 Dec 2015-271
30 Sep 2012-250
30 Jun 2011-250
31 Mar 209-350
31 Dec 1910-360
30 Sep 1911-360
30 Jun 1911-460
31 Mar 1912-360
31 Dec 1813-260
30 Sep 1813-160
30 Jun 1814-160
31 Mar 1813-160
31 Dec 1710-260
30 Sep 176-350
30 Jun 175-340
31 Mar 174-340
31 Dec 164-440
30 Sep 16-6-3-30
30 Jun 16-3-2-20
31 Mar 16-2-2-10
31 Dec 153-230
30 Sep 1521-3151
30 Jun 1522-7161
31 Mar 1522-8171
31 Dec 1422-8171
30 Sep 1423-7171
30 Jun 1424-2161
31 Mar 1424-1151
31 Dec 13250151
30 Sep 13250161
30 Jun 13240151

利益率の向上: PRPHは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: PRPHは利益を出していないが、過去 5 年間で年間1.4%の割合で損失を削減してきた。


株主資本利益率


総資産利益率


使用総資本利益率


過去の好業績企業の発掘